Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | 1 | 1802070 | IM / LA |
Reported Symptoms: 10016558:FEVER; Narrative: Patient was a 73 y/o with hx of follicular lymphoma undergoing R-CHOP who was admitted and given COVID-19 vaccine. Patient experienced fevers (which occurred prior to vaccination) that continued with chemotherapy. Since fevers lasted several weeks, provider entered as adverse reaction. Other Relevant HX: Patient also received R-CHOP chemotherapy on 3/5/2021. Patient was admitted to the hospital 3/5/2021 until 3/21/2021. At time of admission, patient presented with subacute onset fevers and night sweats (and actually received vaccine following admission, so additional factors likely contributed to noted ADR of fevers). The following was indicated on patient's discharge summary: SECONDARY DISCHARGE DIAGNOSES: - Right groin abscess s/p I&D (02/25/2021) with wound vac (removed 3/22/21) - Type 2 diabetes mellitus compounded by steroid-induced hyperglycemia - Hypertension - Hyperlipidemia - Coronary artery disease - Depression - Fever, unspecified Other: FEVER
Labs: WBC: 24.8 K/uL H (03/06/2021 05:24) Hgb: 10.9 g/dL L (03/06/2021 05:24) HCT: 33.0 % L (03/06/2021 05:24) Plt: 301 K/uL (03/06/2021 05:24)